Comments
Loading...
Theravance Biopharma (NASDAQ:TBPH) Stock, Earnings Estimates, EPS, And Revenue
Theravance Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 24
EPS Estimate
$-0.200
Quarterly Revenue Estimate
$16.20M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$63.19M
Analyze the earnings history of Theravance Biopharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Theravance Biopharma (TBPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.06 | $-0.23 | 73.9 % |
| Q2 | 2024-08-05 | $-0.13 | $-0.21 | 38.1 % |
| Q1 | 2024-05-13 | $-0.09 | $-0.25 | 64.0 % |
| Q4 | 2024-02-26 | $-0.17 | $-0.15 | -13.3 % |
Theravance Biopharma (TBPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $16.87M | $15.34M | 9.96 % |
| Q2 | 2024-08-05 | $14.26M | $15.45M | -7.73 % |
| Q1 | 2024-05-13 | $14.50M | $13.96M | 3.89 % |
| Q4 | 2024-02-26 | $17.57M | $17.68M | -0.65 % |
FAQ
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
Theravance Biopharma (TBPH) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Theravance Biopharma (NASDAQ:TBPH)?
The Actual EPS was $-0.06, which beat the estimate of $-0.23.
What were Theravance Biopharma’s (NASDAQ:TBPH) revenues?
The Actual Revenue was $16.9M, which beat the estimate of $15.3M.
Browse earnings estimates, EPS, and revenue on all stocks.